Search research articles
Contact Us
Filters
Showing results (471-480 of 488) with videos related to
Page
of 49
Sort By:
The New England Journal of Medicine
|
October 31, 2019
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML
Alexander E Perl, Giovanni Martinelli, Jorge E Cortes, et al.
Leukemia
|
June 11, 2004
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia
C Terre, V Eclache, P Rousselot, et al.
American Journal of Hematology
|
February 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study
Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard, et al.
The Journal of Experimental Medicine
|
June 16, 2010
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency
Jolan E Walter, Francesca Rucci, Laura Patrizi, et al.
Hemasphere
|
July 14, 2025
Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with <i>TP53</i> mutant MDS/AML
David A Sallman, Rami S Komrokji, Amy E Dezern, et al.
Blood
|
February 4, 2012
B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice
Mike Recher, Siobhan O Burns, Miguel A de la Fuente, et al.
Leukemia
|
March 31, 2022
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
Justine Decroocq, Rudy Birsen, Camille Montersino, et al.
The Journal of Allergy and Clinical Immunology
|
January 18, 2015
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency
Claudia Wehr, Andrew R Gennery, Caroline Lindemans, et al.
Leukemia
|
May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement
Benoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
The Lancet. Oncology
|
August 4, 2015
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
Farhad Ravandi, Ellen K Ritchie, Hamid Sayar, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 488) with videos related to
Sort By:
Page
of 49
The New England Journal of Medicine
|
October 31, 2019
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML
Alexander E Perl, Giovanni Martinelli, Jorge E Cortes, et al.
Leukemia
|
June 11, 2004
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia
C Terre, V Eclache, P Rousselot, et al.
American Journal of Hematology
|
February 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study
Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard, et al.
The Journal of Experimental Medicine
|
June 16, 2010
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency
Jolan E Walter, Francesca Rucci, Laura Patrizi, et al.
Hemasphere
|
July 14, 2025
Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with <i>TP53</i> mutant MDS/AML
David A Sallman, Rami S Komrokji, Amy E Dezern, et al.
Blood
|
February 4, 2012
B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice
Mike Recher, Siobhan O Burns, Miguel A de la Fuente, et al.
Leukemia
|
March 31, 2022
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
Justine Decroocq, Rudy Birsen, Camille Montersino, et al.
The Journal of Allergy and Clinical Immunology
|
January 18, 2015
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency
Claudia Wehr, Andrew R Gennery, Caroline Lindemans, et al.
Leukemia
|
May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement
Benoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
The Lancet. Oncology
|
August 4, 2015
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
Farhad Ravandi, Ellen K Ritchie, Hamid Sayar, et al.
Page
of 49